EMA shortages Shortage ongoing Medicine shortages
NovoSeven (eptacog alfa) — supply shortage (shortage ongoing)
Published by European Medicines Agency:
Summary
Supply shortage
Medicine
NovoSeven (eptacog alfa)
- Category
- Medicine shortages
- Product type
- Human medicine
- Active substance (INN): eptacog alfa (activated)
- Pharmaceutical forms affected: Powder and solvent for solution for injection
- Strengths affected: 1, 2, 5 and 8 mg (50, 100, 250 and 400 KIU)
- Expected resolution: December 2025
- Last updated: 05/06/2025
Measures and alternatives
- Availability of alternatives: Unknown
Source: EMA — medicine shortages — European Medicines Agency
Source: European Medicines Agency (EMA). Reproduced with acknowledgement of the source, in line with the EMA legal notice. EU Safety Radar is an independent information service; the text above presents the official data in the original language — the notice published by the authority is authoritative.
Open the original notice (www.ema.europa.eu) ↗